Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Vaccine administration decision making: the case of yellow fever vaccine.

Lown BA, Chen LH, Wilson ME, Sisson E, Gershman M, Yanni E, Jentes ES, Hochberg NS, Hamer DH, Barnett ED.

Clin Infect Dis. 2012 Sep;55(6):837-43. doi: 10.1093/cid/cis520. Epub 2012 Jun 5.

PMID:
22670048
2.

Preferences and decision needs of Boston-area travelers to countries with risk of Yellow fever virus transmission: implications for health care providers.

Lown BA, Chen LH, Han PV, Jentes ES, Wilson ME, Benoit CM, Avery KA, Ooi W, Hamer DH, Barnett ED; Boston Area Travel Medicine Network.

J Travel Med. 2014 Jul-Aug;21(4):266-71. doi: 10.1111/jtm.12119. Epub 2014 Apr 16.

3.

Travel characteristics and yellow fever vaccine usage among US Global TravEpiNet travelers visiting countries with risk of yellow fever virus transmission, 2009-2011.

Jentes ES, Han P, Gershman MD, Rao SR, LaRocque RC, Staples JE, Ryan ET; Global TravEpiNet Consortium.

Am J Trop Med Hyg. 2013 May;88(5):954-61. doi: 10.4269/ajtmh.12-0463. Epub 2013 Mar 4.

4.

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27.

5.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Monath TP.

Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Review.

PMID:
22551029
6.

Late vaccination against yellow fever of travelers visiting endemic countries.

Krief I, Goldblatt JG, Paz A, Potasman I.

Travel Med Infect Dis. 2006 Mar;4(2):94-8.

PMID:
16887731
7.

Evaluation of travel medicine practice by yellow fever vaccination centers in England, Wales, and Northern Ireland.

Boddington NL, Simons H, Launders N, Gawthrop M, Stillwell A, Wong C, Mathewson J, Hill DR.

J Travel Med. 2012 Mar-Apr;19(2):84-91. doi: 10.1111/j.1708-8305.2011.00587.x. Epub 2012 Feb 24.

8.

Yellow fever vaccine: an effective vaccine for travelers.

Verma R, Khanna P, Chawla S.

Hum Vaccin Immunother. 2014;10(1):126-8. doi: 10.4161/hv.26549. Epub 2013 Sep 20.

9.

Adverse event reports following yellow fever vaccination.

Lindsey NP, Schroeder BA, Miller ER, Braun MM, Hinckley AF, Marano N, Slade BA, Barnett ED, Brunette GW, Horan K, Staples JE, Kozarsky PE, Hayes EB.

Vaccine. 2008 Nov 11;26(48):6077-82. doi: 10.1016/j.vaccine.2008.09.009. Epub 2008 Sep 20.

PMID:
18809449
10.

Risk of fatal adverse events associated with 17DD yellow fever vaccine.

Struchiner CJ, Luz PM, Dourado I, Sato HK, Aguiar SG, Ribeiro JG, Soares RC, Codeço CT.

Epidemiol Infect. 2004 Oct;132(5):939-46.

11.

Transfusion-related transmission of yellow fever vaccine virus--California, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Jan 22;59(2):34-7.

12.

Yellow fever vaccination: is one dose always enough?

Patel D, Simons H.

Travel Med Infect Dis. 2013 Sep-Oct;11(5):266-73. doi: 10.1016/j.tmaid.2013.08.007. Epub 2013 Sep 5. Review.

PMID:
24074827
13.

Yellow fever vaccination: how much is enough?

Massad E, Coutinho FA, Burattini MN, Lopez LF, Struchiner CJ.

Vaccine. 2005 Jun 10;23(30):3908-14. Epub 2005 Apr 2.

PMID:
15917112
14.

Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010.

Breugelmans JG, Lewis RF, Agbenu E, Veit O, Jackson D, Domingo C, Böthe M, Perea W, Niedrig M, Gessner BD, Yactayo S; YF AEFI group.

Vaccine. 2013 Apr 3;31(14):1819-29. doi: 10.1016/j.vaccine.2013.01.054. Epub 2013 Feb 7.

PMID:
23395587
15.

Quality of travel health advice in a French travel medicine and vaccine center: a prospective observational study.

Bouldouyre MA, De Verdière NC, Pavie J, De Castro N, Ponscarme D, Hamane S, Rachline A, Ferret S, Molina JM.

J Travel Med. 2012 Mar-Apr;19(2):76-83. doi: 10.1111/j.1708-8305.2011.00591.x. Epub 2012 Feb 24.

16.

Yellow fever: epidemiology and prevention.

Barnett ED.

Clin Infect Dis. 2007 Mar 15;44(6):850-6. Epub 2007 Feb 1. Review.

PMID:
17304460
17.

Prevention of yellow fever in persons traveling to the tropics.

Monath TP, Cetron MS.

Clin Infect Dis. 2002 May 15;34(10):1369-78. Epub 2002 Apr 25. Review. Erratum in: Clin Infect Dis 2002 Jul 1;35(1):110.

PMID:
11981733
18.

No booster dose for yellow fever vaccination: what are the consequences for the activity of vaccination in travel clinics?

Wyplosz B, Leroy JP, Derradji O, Consigny PH.

J Travel Med. 2015 Mar-Apr;22(2):140-1. doi: 10.1111/jtm.12173. Epub 2014 Nov 11.

19.

The reliability of pre-travel history to decide on appropriate counseling and vaccinations: a prospective study.

Rossi IA, Genton B.

J Travel Med. 2012 Sep-Oct;19(5):284-8. doi: 10.1111/j.1708-8305.2012.00618.x.

20.

Immunogenicity and tolerability of yellow fever vaccination in 23 French HIV-infected patients.

Pistone T, Verdière CH, Receveur MC, Ezzedine K, Lafon ME, Malvy D.

Curr HIV Res. 2010 Sep;8(6):461-6.

PMID:
20636276

Supplemental Content

Support Center